Somatic pathogenic mutations in NF1 are found in approximately 4.7%–10% of NSCLC, with a higher frequency in lung adenocarcinomas, reaching up to 15% in certain cohorts. The gene discussed is NF1; the disease is non-small cell lung carcinoma.